Malte Greune
Chief Operating Officer chez CUREVAC N.V.
Fortune : 6 299 $ au 31/03/2024
Profil
Malte Greune occupe le poste de Chief Operating & Production Officer chez CureVac NV. Auparavant, il a occupé le poste de VP-Cartouches, Devices & Insulin Technology Group chez Sanofi-Aventis Deutschland GmbH. Il a obtenu un doctorat de l'Universitt zu Kln, un diplôme de premier cycle de l'Université de Trèves et un MBA de l'Université Clark.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CUREVAC N.V.
0,00% | 31/03/2023 | 2 079 ( 0,00% ) | 6 299 $ | 31/03/2024 |
Postes actifs de Malte Greune
| Sociétés | Poste | Début |
|---|---|---|
| CUREVAC N.V. | Chief Operating Officer | 01/07/2021 |
Anciens postes connus de Malte Greune
| Sociétés | Poste | Fin |
|---|---|---|
Sanofi-Aventis Deutschland GmbH
 Sanofi-Aventis Deutschland GmbH Pharmaceuticals: MajorHealth Technology Sanofi-Aventis Deutschland GmbH engages in the development, manufacture, and packaging of medicines, as well as pharmaceutical products. It also focuses on the research into the causes of diseases and the search for its drug treatment. The company was founded in 2004 and is headquartered in Frankfurt, Germany. | Corporate Officer/Principal | - |
Formation de Malte Greune
| Clark University | Masters Business Admin |
| Universität zu Köln | Doctorate Degree |
| University of Trier | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CUREVAC N.V. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Sanofi-Aventis Deutschland GmbH
Sanofi-Aventis Deutschland GmbH Pharmaceuticals: MajorHealth Technology Sanofi-Aventis Deutschland GmbH engages in the development, manufacture, and packaging of medicines, as well as pharmaceutical products. It also focuses on the research into the causes of diseases and the search for its drug treatment. The company was founded in 2004 and is headquartered in Frankfurt, Germany. | Health Technology |
